DiscoverOTO JournalElevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy
Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy

Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy

Update: 2025-04-29
Share

Description

Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author David Goldenberg, MD, to discuss role of estrogen in developing thyroid malignancy as outlined in the paper “Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy” which published in the April 2025 issue of Otolaryngology–Head and Neck Surgery. They talk about the risk of thyroid cancer for biological males taking estrogen compared to men not undergoing hormone therapy and women.

 

Click here to read the full article.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy

Elevated Risk of Thyroid Malignancy in Biological Males Taking Estrogen Hormone Therapy

AAO-HNS